Transwestern Investment Group completes its largest fundraise to date by Kali Persall | Oct 27, 2022 Transwestern Investment Group (TIG), a real estate investment adviser with $7.3 billion of assets under management, has raised $325 million of commitments for its Transwestern Strategic Partners Fund III (TSP Fund III) — the firm’s largest fundraise to date.
Ascend Elements secures $300m in funding by Andrea Zander | Oct 27, 2022 Ascend Elements, a U.S.-based engineered materials and lithium-ion battery recycling company, has secured $300 million in equity and debt financing, including $200 million in Series C equity investments, from an international group of strategic and financial investors.
Hamilton Lane partners with Figure to launch blockchain-native registered investment fund by Released | Oct 27, 2022 Figure Technologies and Hamilton Lane have plans to launch three new share classes of Hamilton Lane's private markets-focused fund.
Aspen Creek Digital Corporation expands operations with new solar-powered Bitcoin mining center in Texas by Released | Oct 26, 2022 Aspen Creek Digital Corporation announced that its second high performance computing center (HPCC) co-located with renewable energy commenced operations in Texas.
Ridgemont Equity Partners closes fourth fund at hard cap with $2.35b in commitments by Released | Oct 26, 2022 Ridgemont Equity Partners has closed its Ridgemont Equity Partners IV (REP IV)l at its hard cap with $2.35 billion in commitments.
Retail real estate encourages comeback in United States by Andrea Zander | Oct 26, 2022 The retail real estate has been mounting an encouraging comeback in the United States, according to Hines in its report.
Abacus Multi-Family Partners VI soars past $1.25b target by Kali Persall | Oct 26, 2022 Abacus Capital Group has secured $1.45 billion for its latest value-add multifamily fund against its target of $1.25 billion, according to a filing with the SEC.
How biotechs can scale faster amid industry challenges by Andrea Zander | Oct 26, 2022 Since 2013, scaling biotech companies — early-stage and fast-growing companies — have brought two-thirds of new therapies to market, and, with billions of dollars of capital deployed into the life sciences sector, the opportunities for positive clinical impact are larger than ever before.
Royal family partners invest in proptech fund by Released | Oct 25, 2022 The Liechtenstein Group has made a key investment in Greensoil PropTech Ventures Fund II, putting the $100 million proptech investment fund on target for a fourth-quarter closing.
BlackRock Global Infrastructure Fund IV raises $4.5b in first close by Kali Persall | Oct 25, 2022 BlackRock Alternatives has captured $4.5 billion of initial investor commitments in a first closing.